Stay updated on Nivolumab Ipilimumab Local Consolidation Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Local Consolidation Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Local Consolidation Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision label changed from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check20 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page now displays a glossary option and includes updated metadata labels such as 'Last Update Submitted that Met QC Criteria' with a revision bump to v3.4.0, and capitalization changes for 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows a revision update to v3.3.4 replacing the previous v3.3.3, with no substantive changes to the study details.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision updated to v3.3.3 with new dates (2025-12-11, 2025-12-17, 2026-03-31) and addition of Texas locations. Older entries including HHS Vulnerability Disclosure, Texas Locations, and the prior revision (v3.3.2) were removed.SummaryDifference0.5%

- Check91 days agoChange DetectedA PubMed publications note was added clarifying that items are automatically filled from PubMed and may not be about the study, and the revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab Local Consolidation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Local Consolidation Clinical Trial page.